AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea · Delayed Price · Currency is KRW 7,020.00
+10.00 (0.14%)
Mar 20, 2026, 3:30 PM KST
AptaBio Therapeutics Market Cap
AptaBio Therapeutics has a market cap or net worth of 197.22 billion as of March 20, 2026. Its market cap has decreased by -9.87% in one year.
Market Cap
197.22B
Enterprise Value
186.43B
Revenue
3.44B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,020.00
Market Cap Chart
Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 197.22B, a decrease of -53.41%. That is a compound annual growth rate of -10.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 197.22B | -21.53% |
| Dec 30, 2025 | 251.34B | 46.78% |
| Dec 30, 2024 | 171.23B | -15.15% |
| Dec 28, 2023 | 201.80B | -15.02% |
| Dec 29, 2022 | 237.48B | -71.24% |
| Dec 30, 2021 | 825.71B | 46.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samjin Pharmaceuticals | 227.26B |
| Suheung | 224.05B |
| HLB Pharmaceutical | 223.27B |
| Daewon Pharmaceutical | 219.91B |
| Jeil Pharmaceutical Co.,Ltd | 210.27B |
| Samil Pharmaceutical Co.,Ltd | 209.75B |
| JW Lifescience | 200.99B |
| Kyongbo Pharmaceutical | 189.82B |